Psoriasis affecting the nails — nail psoriasis — is a specific presentation that may require targeted intervention, particularly when lesions are localised, very thick, or nonresponding to initial treatment.
This protocol addresses psoriasis presenting as nail psoriasis. It is relevant when nail lesions are localised and either do not respond adequately or present as very thick nail changes.
For localised nail lesions that are nonresponding or very thick, an intralesional corticosteroid approach is one option addressed in this protocol.
DOI: 10.1016/j.jaad.2020.07.087
Topical tazarotene can be used for the treatment of nail psoriasis.
Additionally, intralesional corticosteroids can be used for localized nonresponding or very thick lesions on glabrous skin, scalp, nails, palms, and soles.
Triamcinolone acetonide in a dose up to 20 mg/mL can be used every 3 to 4 weeks.
View source ↗